what are glp-1 weight loss drugs Patent and Innovation Trends in and (2020–2025) GLP-1 Agonists: A Comprehensive Overview

One such substance, LY3437943, has been discovered to exhibit strong agonist activity on three distinct receptors, including the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors

Its once-weekly injections make it convenient

There are a lot of very interesting questions ahead of us. Drucker DJ

Methods Participants Data were collected between July 2023 and May 2024

It is important to note that there is no established direct causative mechanism linking GLP-1 receptor activation to increased gastric acid production or lower esophageal sphincter dysfunction

The final section of this review synthesizes these insights into a forward-looking perspective on the future of peptide therapeutics and articulates why the rediscovery of dormant biology, when guided by modern pharmacologic principles, may represent the most productive frontier in drug discovery